Search


	Podcast:		OncLive® On Air
	Episode:		47: FDA Approval Insights: Trilaciclib in Extensive-Stage Small Cell Lung Cancer
	Category:		Science & Medicine
	Duration:		00:18:43
	Publish Date:		2021-04-08 20:51:05
	Description:		In our exclusive interview, Weiss discussed the significance of the FDA approval of trilaciclib in extensive-stage small cell lung cancer and key efficacy and safety data that have been reported with the CDK4/6 inhibitor.
	Total Play:		0